EP3066203

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
Application Number
EP14793193A
Filing Date
Nov 5, 2014
Status
Patent Maintained As Amended
Oct 6, 2023
Grant Date
Nov 8, 2023
External Links
Slate, Register

Biblio Summary

The patent EP3066203B2 was granted on Nov 8, 2023 by Centre National De La Recherche Scientifique (Cnrs) The patent is currently Patent Maintained As Amended.

The table below shows 1 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

CHRISTOPH THEN/RUTH TIPPE/ SYLVIA HAMBERGERMar 22, 2021ADMISSIBLE

The table below shows the patents of Centre National De La Recherche Scientifique (Cnrs) that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP3911354Aav-Mediated Gene Therapy Restoring The Otoferlin GeneApr 3, 20244
EP2988757Treatment Of Skin Injuries Associated With Auto-Immune And Inflammatory Diseases Using The Arsenic Compound As2O5Jan 12, 20221
EP2900820Methods For Producing A Population Of Pancreatic Beta-CellsNov 18, 20201

Dossier Documents of the Patent

The documents dossier of the patent at EPO including all essential records in the patent's lifecycle, from filing to grant to oppositions.